Sma: Roche's SMA drug 15x costlier in India than in China & Pak | India News
India News: MUMBAI: Global pharma giant Roche's critical rare disease drug in India costs up to 15 times more than neighbouring China and Pakistan.
Stay updated with breaking news from Visma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India News: MUMBAI: Global pharma giant Roche's critical rare disease drug in India costs up to 15 times more than neighbouring China and Pakistan.
The stock market witnessed several noteworthy stocks crossing their 20-day Simple Moving Averages (SMA), indicating strong market momentum and potential bullish trends.
This article sheds light on the significance of the Golden Crossover and its relevance in assessing stock movements. With data from Trendlyne reporting over 40 Nifty50 stocks experiencing this pattern on August 16, Wednesday, and ETMarkets selecting 10 stocks, discover how this pattern can shape informed investment choices.
PARIS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today the positive results of the multi-center,...
All the options to follow the last grand tour of the year